IQVIA Holdings Inc. IQV and Genomics England recently announced that they have partnered to build a real-world research platform, which integrates clinical and de-identified genomics data.Genomics England is a company under the U.K. government’s Department of Health and Social Care. It was formed with the goal of sequencing 100,000 whole genomes from NHS patients and their families.IQVIA Offering Healthcare Analytics SolutionUnder the partnership, IQVIA will offer its E360 analytics technology to authorized users of Genomics England's database of de-identified genomic and phenotypic records. As a result, users will be able to develop custom clinical-genomic datasets and run analytics on genomics and observable traits.The initiative focuses on patients with rare diseases as well as common cancer, and is expected to facilitate faster and more efficient drug research, stronger evidence to support treatment value, and greater access to personalized medicines.The integrated genomic-clinical build of E360 will go online in 2019, after which the duo plans to serve academic and commercial researchers in genotype-phenotype association studies, comparative efficacy and safety trials, and burden-of-illness analytics. E360 is IQVIA’s extensible platform for delivering real-world Insights.IQVIA’s Technology & Analytics Solutions Segment to BenefitWe believe that the recent collaboration will help boost IQVIA’s Technology & Analytics Solutions segment that delivers critical information, technology solutions and real-world insights and services to life science customers.In the last reported quarter, the segment performed well with revenues totaling $1.01 billion, up 14.2% on a reported basis and 13.1% on a constant-currency basis.With partnerships like this latest one, IQVIA is trying to keep itself ahead of its competitors like Verisk VRSK, Accenture ACN and International Business Machines Corporation IBM.Wall Street’s Next AmazonZacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.Click for details >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report International Business Machines Corporation (IBM): Free Stock Analysis Report Verisk Analytics, Inc. (VRSK): Free Stock Analysis Report Accenture PLC (ACN): Free Stock Analysis Report IQVIA Holdings Inc. (IQV): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research